Evidence map›Paper›PMID 28533835›Full record

ArticleThe Pan African medical journal2017

[Primary colonic extranasal NK/T-cell lymphoma: about a case].

Salma Fares, Mouna Lamchahab, Myriem Aniba, Ghizlane Lembarki, Nadia Mousalli, Meriem Regragui, Mehdi Karkouri, Asmaa Quessar

Open access · greenAbstract readCase Reports
In one paragraph

Article in The Pan African medical journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 7 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Salma FaresService d'Hématologie et d'Oncologie Pédiatrique, Hôpital 20 Août 1953, CHU Ibn Rochd, Casablanca, Maroc.
Mouna LamchahabService d'Hématologie et d'Oncologie Pédiatrique, Hôpital 20 Août 1953, CHU Ibn Rochd, Casablanca, Maroc.
Myriem AnibaService d'Hématologie et d'Oncologie Pédiatrique, Hôpital 20 Août 1953, CHU Ibn Rochd, Casablanca, Maroc.
Ghizlane LembarkiService de Radiologie de l'Hôpital 20 Août 1953, CHU Ibn Rochd, Casablanca, Maroc.
Nadia MousalliService de Radiologie de l'Hôpital 20 Août 1953, CHU Ibn Rochd, Casablanca, Maroc.
Meriem RegraguiService Central d'Anatomie Pathologique, CHU Ibn Rochd, Casablanca, Maroc.
Mehdi KarkouriService Central d'Anatomie Pathologique, CHU Ibn Rochd, Casablanca, Maroc.
Asmaa QuessarService d'Hématologie et d'Oncologie Pédiatrique, Hôpital 20 Août 1953, CHU Ibn Rochd, Casablanca, Maroc.
Hôpital 20 Août · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To better understand this cancer, we here report the case of a 43-year old patient diagnosed with localized and isolated primary colonic NK/T-cell lymphoma without associated enteropathy, treated wih 3 cycles of AspaMetDex with a poor response who died during treatment with a clinical picture of acute abdomen. Primary intestinal NK/T-cell lymphoma most commonly affects the young subject with poor prognosis. It is difficult to distinguish between intestinal NK/T-cell lymphoma and inflammatory or infectious intestinal disorders because of its non-specific clinical and endoscopic features. The histopathological and immunohistochemical data as well as the study of DNA allow to adjust the diagnosis and to classify this lymphoma according the European Enteropathy type T-cell lymphoma (ETL).

Indexed as

AdultAntineoplastic Combined Chemotherapy ProtocolsAsparaginaseColonic NeoplasmsDexamethasoneHumansLymphoma, Extranodal NK-T-CellMaleMethotrexatePrognosisAsparaginaseDexamethasoneMethotrexatecolicenteropathyextra-nasalT/NK lymphoma

Identifiers

PMID28533835
PMCPMC5429424
OpenAlexW3023148974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.